Search Results

An online guide to clarify drug interactions between rifamycins and drugs commonly used in primary care. This is meant for primary care and other health professionals.

This fact sheet provides clinicians with steps to recognize signs of TB, diagnose via a full evaluation, and report probable and confirmed cases to their local health department.

This second edition manual includes information and resources to support the implementation of TB infection prevention and control measures. This material is intended to be used in efforts to reduce the risk of tuberculosis transmission in health and community care settings.

This fact sheet provides information about active TB disease, latent TB infection, TB transmission, and signs and symptoms of TB disease. The resource also includes information on TB testing and treatment.

This fact sheet provides information about active TB disease, latent TB infection, TB transmission, and signs and symptoms of TB disease. The resource also includes information on TB testing and treatment.

This fact sheet provides information about active TB disease, latent TB infection, TB transmission, and signs and symptoms of TB disease. The resource also includes information on TB testing and treatment.

This poster aims to remind health professionals to continue to consider TB in patients presenting with symptoms and risk factors consistent with TB, regardless of their COVID-19 status.

This fact sheet aims to provide clinicians with general information on the presence of nitrosamine impurities found in rifampin and rifapentine and its impact on the treatment for TB.

This fact sheet provides general information on distinguishing between TB and COVID-19 symptoms, as well as information on some risk factors for TB.

This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.